Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum mitochondrion is a single, double-membrane-bound organelle differing substantially from mammalian mitochondria, both structurally and biochemically. It possesses a single copy per parasite and displays marked differences in size, cristae density and morphology at different life stages[1][4][7]. Metabolically, it is essential for the parasite's survival, supporting ATP production and, critically, serving as a source of reducing power for de novo pyrimidine synthesis, making it indispensable for parasite proliferation. The electron transport chain, particularly complex III (the cytochrome bc1 complex), is a validated therapeutic target; it is the molecular target of the antimalarial drug atovaquone, as well as several experimental inhibitors[3][9]. Inhibition of the mitochondrial electron transport chain results in loss of mitochondrial membrane potential, disruption of pyrimidine biosynthesis, and impaired ATP production, which collectively lead to cytostasis or cell death in P. falciparum[3]. Recent studies have also identified unique, parasite-specific subunits within mitochondrial complexes, increasing the feasibility of selective targeting for antimalarial drug discovery[9][10]. The mitochondrion is especially important in sexual (gametocyte) stages, with increased cristae density and distinctive metabolic activity[1][4][7]. The uniqueness of P. falciparum mitochondrial metabolism underpins its value as a current and future antimalarial drug target.
Inhibition of electron transport (especially at complex III, cytochrome bc1 complex) Collapse of mitochondrial membrane potential (ΔΨm) Inhibition of pyrimidine biosynthesis, leading to parasite cytostasis or death Disruption of ATP synthesis (energy depletion for parasite)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum mitochondrion.